Sodium taurocholate affects prostacyclin constitutive production by cultured human vascular endothelial cells. 1990

G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
Clinica Medica Generale III, Dipartimento di Scienze cliniche e biologiche, Universitá di Torino, Italy.

The prostaglandin system is impaired in cholestasis; bile salts, which are a specific biochemical feature of this condition, have been shown to affect functional properties of cells and tissues, and, in some cases, their action is mediated through an alteration of prostaglandin pathway. Endothelium is a privileged site for the production and the action of arachidonate metabolites-prostacyclin in particular. To determine the effects of bile salts on the properties of vascular endothelium, cultured human endothelial cells were studied. Cholic acid sodium salt was seen to induce a direct injury on endothelial cells, as was demonstrated by a massive dismission of the intracellular radiolabel chromium 51. In the absence of detectable toxic effect, sodium taurocholate caused a significant depression of prostacyclin constitutive production from human endothelial cells. The action of sodium taurocholate was related to its concentration and to the time of exposure, and the alteration of prostacyclin production was found to be reversible. Conversely, the generation of thromboxane A2 was not influenced by this bile salt, which may suggest a specific action of sodium taurocholate on arachidonic acid metabolism. These findings indicate that bile salts may directly alter some functional properties of cultured human endothelial cells and may provide a basis for explaining some generalized manifestations that are observed in pathologic conditions characterized by cholemia.

UI MeSH Term Description Entries
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013656 Taurocholic Acid The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic. Cholyltaurine,Taurine Cholate,Taurocholate,Sodium Taurocholate,Taurocholate Sodium,Taurocholic Acid, (5 alpha)-Isomer,Taurocholic Acid, (7 beta)-Isomer,Taurocholic Acid, Monolithium Salt,Taurocholic Acid, Monosodium Salt,Taurocholate, Sodium
D013928 Thromboxane A2 An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Rabbit Aorta Contracting Substance,A2, Thromboxane
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
March 1991, The Journal of clinical endocrinology and metabolism,
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
January 1984, The Journal of clinical investigation,
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
April 1988, Thrombosis and haemostasis,
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
February 1987, Transplantation proceedings,
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
March 1985, Science (New York, N.Y.),
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
December 1983, Journal of lipid research,
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
December 1982, Diabete & metabolisme,
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
November 1983, Bioscience reports,
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
December 1993, Thrombosis and haemostasis,
G Calcamuggi, and M Lanzio, and G Babini, and S Martini, and G Anfossi, and G Emanuelli
January 1979, Haemostasis,
Copied contents to your clipboard!